Arcataur Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$285K Buy
3,108
+55
+2% +$4.81K 0.07% 91
2026
Q1
$260K Sell
3,053
-15
-0.5% -$1.34K 0.07% 93
2025
Q4
$242K Hold
3,068
0.07% 93
2025
Q3
$245K Sell
3,068
-125
-4% -$10.7K 0.07% 93
2025
Q2
$290K Sell
3,193
-5
-0.2% -$456 0.09% 90
2025
Q1
$300K Sell
3,198
-290
-8% -$26K 0.1% 88
2024
Q4
$317K Hold
3,488
0.11% 83
2024
Q3
$362K Sell
3,488
-7
-0.2% -$713 0.12% 79
2024
Q2
$339K Sell
3,495
-15
-0.4% -$1.38K 0.12% 82
2024
Q1
$316K Hold
3,510
0.11% 83
2023
Q4
$280K Sell
3,510
-15
-0.4% -$1.13K 0.11% 85
2023
Q3
$251K Hold
3,525
0.1% 82
2023
Q2
$272K Buy
+3,525
New +$273K 0.11% 85

Other funds holding CL

Arcataur Capital Management's CL Position: Q2 2026 in Review

Arcataur Capital Management increased its Colgate-Palmolive (CL) stake by 1.8% in Q2 2026, buying an estimated $4.81K and bringing the position to 3,108 shares worth $285K. The position accounts for 0.07% of the portfolio, ranked #91.

Arcataur Capital Management first reported a position in CL in Q2 2023 and has held it in 13 quarters since. The position peaked at $362K in Q3 2024. 658 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Arcataur Capital Management held 3,108 shares of Colgate-Palmolive worth $285K as of Q2 2026.
  • Arcataur Capital Management bought 55 Colgate-Palmolive shares in Q2 2026, an estimated $4.81K.
  • Colgate-Palmolive made up 0.07% of Arcataur Capital Management's portfolio in Q2 2026, its #91 holding.
  • Arcataur Capital Management first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 13 quarters since.
  • Arcataur Capital Management's Colgate-Palmolive position peaked at $362K in Q3 2024.
  • 658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Arcataur Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.